Main Activity in Nanotechnology
MagneCell Limited was formed in March 2003 to exploit novel technology from biomedical research at Keele University and the North Staffordshire NHS Trust.
The patented technology concerns a new type of bioreactor for use in tissue engineering.
Although in its early stages, tissue engineering aims to replace damaged tissues with healthy tissues grown from a patient's own cells or from a cell-line which does not trigger an immune response reaction in the patient.
The MagneCell bioreactor represents a significant leap forward in enabling tissue engineering to progress towards its ultimate clinical goal.
Centre for Science and Technology in Medicine